March 26, 2017 9:51 AM ET

Pharmaceuticals

Company Overview of KAHR medical Ltd.

Company Overview

KAHR medical, Ltd. develops fusion protein pharmaceuticals for the treatment of autoimmune diseases. The company’s drugs include KAHR-101 and KAHR-102 that are used for the treatment of psoriasis and rheumatoid arthritis. The company was founded in 2005 and is based in Jerusalem, Israel.

Hadassah Medical Center

Jerusalem,  91120

Israel

Founded in 2005

Phone:

972 4 629 2112

Fax:

972 4 629 2112

Key Executives for KAHR medical Ltd.

Chief Executive Officer
Age: 53
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
Abital Pharma Pipelines Ltd. Middle East/Africa
Active PX Ltd. Middle East/Africa
Advanced Inhalation Technology Ltd. Middle East/Africa
AIT Therapeutics, Inc. Middle East/Africa
Angio B Ltd. Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KAHR medical Ltd., please visit www.kahr-medical.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.